federal_register: 2020-13346

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2020-13346 Hospira, Inc., et al.; Withdrawal of Approval of 12 Abbreviated New Drug Applications; Correction Notice The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of February 12, 2019. The document announced the withdrawal of approval of 12 abbreviated new drug applications (ANDAs) from multiple applicants. The document erroneously included ANDA 077736 for Polyethylene Glycol 3350 Powder for Oral Solution, 17 grams/scoopful, held by Breckenridge Pharmaceutical, Inc. (Breckenridge). This document corrects that error. 2020-06-22 2020 6 https://www.federalregister.gov/documents/2020/06/22/2020-13346/hospira-inc-et-al-withdrawal-of-approval-of-12-abbreviated-new-drug-applications-correction https://www.govinfo.gov/content/pkg/FR-2020-06-22/pdf/2020-13346.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of February 12, 2019. The document announced the withdrawal of approval of 12 abbreviated new drug applications (ANDAs) from multiple applicants. The...  

Links from other tables